(Q39614979)

English

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder

scientific article published on 3 January 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin (AMVAC) as neoadjuvant chemotherapy for patients with muscle-invasive transitional cell carcinoma of the bladder (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

transitional cell carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Christopher Blick

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Peter Hall

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Thinn Pwint

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Faisal Al-Terkait

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Jeremy Crew

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Thomas Powles

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Valentine Macaulay

7

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Nicholas Munro

8

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

David Douglas

9

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Neviana Kilbey

10

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Andrew Protheroe

11

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

John D Chester

12

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

language of work or name

0 references

publication date

3 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

118

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

3920-3927

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Cancer statistics, 2009

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Management of muscle-invasive bladder cancer: an update

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Neoadjuvant chemotherapy for the treatment of muscle-invasive bladder cancer: argument in favor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Neoadjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Neoadjuvant chemotherapy in invasive bladder cancer: update of a systematic review and meta-analysis of individual patient data advanced bladder cancer (ABC) meta-analysis collaboration

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

International phase III trial assessing neoadjuvant cisplatin, methotrexate, and vinblastine chemotherapy for muscle-invasive bladder cancer: long-term results of the BA06 30894 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Delay and survival in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

A role for neoadjuvant gemcitabine plus cisplatin in muscle-invasive urothelial carcinoma of the bladder: a retrospective experience

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Lack of pathologic down-staging with neoadjuvant chemotherapy for muscle-invasive urothelial carcinoma of the bladder: a contemporary series

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

P0 stage at radical cystectomy for bladder cancer is associated with improved outcome independent of traditional clinical risk factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

The updated EAU guidelines on muscle-invasive and metastatic bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Clinical value of fluorine-18 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

7 January 2021

based on heuristic

inferred from DOI database lookup

Kuhn's paradigms: are those closest to treating bladder cancer the last to appreciate the paradigm shift?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

7 January 2021

based on heuristic

inferred from DOI database lookup

Delaying Radical Cystectomy for Muscle Invasive Bladder Cancer Results in Worse Pathological Stage

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment delay and prognosis in invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

7 January 2021

based on heuristic

inferred from DOI database lookup

Neoadjuvant chemotherapy: a new treatment paradigm for muscle-invasive bladder cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction chemotherapy for unresectable urothelial carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26675

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.26675

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39614979&oldid=1845447697"